The test can detect carriers of the virus, whether they are sick or asymptomatic carriers. It is an automated test, less dependent on reagents at risk of shortage and requiring a reduced number of operators.
Une étude internationale menée notamment par le laboratoire SportS2 démontre que faire une activité physique alors que l’on est infecté par le COVID-19 pourrait être dangereux pour le coeur.
Mobilization is general at ULiège to better understand the disease, to amplify testing capacities and to support the medical teams on the front line in hospitals.
The GIGA has taken the initiative to create a Covid-19 working group in close collaboration with the CHU de Liège and FARAH.
Alain Chariot's team (GIGA-Stem Cells, Laboratory of Medical Chemistry) publishes the results of this study today in the journal “Nature Communications”.
Research work of Akeila Bellahcène (GIGA-Cancer, ULiège) identifies a natural molecule, the carnosine, produced by our body, taht lifts the resistance of colon cancer cells to targeted therapy.
Congratulations to Cécile, head of the Cardiology laboratory (GIGA-Cardiovascular), for this great recognition after 20 years of research in this field!
Funding includes €13.9M in equity and €6.1M in grants; will support company’s phase I/II trial with PDC*lung01 candidate in lung cancer.
Winner of the Prix Francqui 2017, Steven Laureys receives the Generet Prize, managed by the King Baudouin Foundation, worth one million euros for research into the "post-coma" period.
Eric Salmon, medical director of the Cyclotron Research Center, receives this prize which rewards a renowned scientist for his research in the field of nuclear energy.
These credits are granted to researchers developping projects of excellence.